Janssen submits sNDA to US FDA for once-daily Olysio in combo with sofosbuvir
Posted on26 Jul 2015
Comments0
Janssen Therapeutics, Division of Janssen Products, LP (Janssen), has submitted a supplemental New Drug Application (sNDA) to the US Food and Drug... Read More